John Libbey Eurotext

Did the COVID-19 pandemic silence the needs of people with epilepsy? Volume 22, numéro 4, August 2020

Tableaux

Auteurs
1 Epilepsy Unit, Department of Pediatric Neuroscience. Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy. Member of ERN EpiCARE
2 IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy. Member of ERN EpiCARE
3 Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
4 Department of Paediatric Clinical Epileptology, Sleep Disorders and Functional Neurology in Children, University Hospitals of Lyon (HCL), Coordinator of the ERN EpiCARE and of the Brain Dynamics and Cognition Team (DYCOG),INSERM U1028, CNRS UMR5292, Lyon Neuroscience Research Center, Lyon, France
5 Research Coordinator, Epilepsy Unit, San Juan de Dios Children's Hospital, Member of the ERN EpiCARE and Universitat de Barcelona, Barcelona, Spain
6 Epilepsy Monitoring Unit, Department of Neurology, Hospital del Mar, Barcelona, Spain. Member of ERN EpiCARE
7 Hospital del Mar Medical Research Institute (IMIM) Barcelona, Spain
* Correspondence: Francesca Bisulli IRCCS Istituto delle Scienze Neurologiche di Bologna, and Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
a Authors contributed equally.

Aims

The COVID-19 pandemic shook European healthcare systems, with unavoidable gaps in the management of patients with chronic diseases. We describe the impact of the pandemic on epilepsy care in three tertiary epilepsy centres from Spain and Italy, the most affected European countries.